John Altomare, MD
Gastroenterology · Wyomissing, PANPI 1932173143
Payments from drug & device makers
Across 395 payments — averaging $566.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$188K
- Gilead$32K
- Johnson & Johnson$551
- Bristol Myers Squibb$412
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$330
- Intercept Pharmaceuticals, Inc.$329
- plus $2K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 176 | $187,905 |
| Gilead | 32 | $32,138 |
| Johnson & Johnson | 34 | $551 |
| Bristol Myers Squibb | 22 | $412 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $330 |
| Intercept Pharmaceuticals, Inc. | 14 | $329 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $291 |
| Pfizer | 14 | $208 |
| Regeneron Healthcare Solutions, Inc. | 8 | $166 |
| E.r. Squibb & Sons, L.L.C. | 2 | $143 |
| Mallinckrodt Hospital Products Inc. | 2 | $142 |
| Ipsen Biopharmaceuticals, Inc | 6 | $120 |
| Madrigal Pharmaceuticals | 4 | $100 |
| Ferring Pharmaceuticals Inc. | 5 | $77 |
| Sanofi | 4 | $77 |
| Phathom Pharmaceuticals, Inc. | 4 | $77 |
| Ironwood Pharmaceuticals, Inc | 5 | $75 |
| Nestle Healthcare Nutrition Inc. | 4 | $63 |
| Ardelyx, Inc. | 3 | $62 |
| Biofire Diagnostics, LLC | 1 | $59 |
| Daiichi Sankyo Inc. | 4 | $57 |
| UCB, Inc. | 4 | $52 |
| Redhill Biopharma Inc. | 2 | $47 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Celltrion USA Inc. | 2 | $41 |
| Braintree Laboratories, Inc. | 1 | $35 |
| Recordati_rare_diseases_inc. | 2 | $33 |
| Shionogi Inc | 1 | $33 |
| Amgen | 1 | $32 |
| QOL Medical, LLC | 2 | $30 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| Merck | 2 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Olympus America Inc. | 1 | $19 |
| Novo Nordisk | 1 | $19 |
How this compares
$223,842 in reported general payments places this provider in the 90th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Wyomissing
- Nirav ShahWyomissing$3.5M
- Kuchikala ReddyPhiladelphia$6.5M
- Glenn FreedPottsville$3.8M
- Jaideep BehariPittsburgh$2.7M
- Adnan AhmadCamp Hill$2.1M
- Frederick RuthardtUniontown$1.7M
- Adam PeytonAllentown$1.6M
- Dina Halegoua de MarzioPhiladelphia$1.5M
- Miguel RegueiroPittsburgh$1.5M
- Gary FalkPhiladelphia$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.